Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
39.20
-0.25 (-0.63%)
May 8, 2026, 1:58 PM CST
TPEX:7427 Market Cap
TPEX:7427 has a market cap or net worth of 1.68 billion as of May 8, 2026. Its market cap has increased by 4.57% in one year.
Market Cap
1.68B
Enterprise Value
1.24B
Revenue
1.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
39.20
Market Cap Chart
Since July 8, 2021, TPEX:7427's market cap has increased from 1.48B to 1.68B, an increase of 13.58%. That is a compound annual growth rate of 2.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 1.68B | 22.19% |
| Dec 31, 2025 | 1.37B | -7.37% |
| Dec 31, 2024 | 1.48B | -42.09% |
| Dec 29, 2023 | 2.56B | 40.55% |
| Dec 30, 2022 | 1.82B | 94.83% |
| Dec 30, 2021 | 935.73M | -36.72% |
| Jul 8, 2021 | 1.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genomics BioSci & Tech. | 2.07B |
| Gwo Xi Stem Cell Applied Technology Co. , | 2.06B |
| Sunny Pharmtech | 1.99B |
| Anti-Microbial Savior BioteQ | 1.90B |
| Synbio Tech | 1.90B |
| TaiRx | 1.86B |
| Greenyn Biotechnology | 1.85B |
| Andros Pharmaceuticals Co.,Ltd | 1.82B |